| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9714 | AMBA acetate |
9714.0001: 1 mg per vial 9714.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
|
||
| Molar Mass: 1502.70 | ||
| C68H99N19O18S | ||
| [721937-56-0] (net peptide) | ||
| Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 97 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: CA index name: L-Methioninamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]glycyl-4-aminobenzoyl-L-glutaminyl-L-tryptophyl -L-alanyl-L-valylglycyl-L-histidyl-L-leucyl- |
||
|
Synonymes: L-Methioninamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]glycyl-4-aminobenzoyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-L-leucyl- |
||
|
Literature: 1. Chen J. et al. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors. Appl Radiat Isot. 2008, 66, 497-505. |
||
| 2. Waser B. et al. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. Eur. J. Nucl. Med. Mol. Imaging. 2007, 34, 95-100. | ||
| 3. Lantry L.E. et al. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J. Nucl. Med. 2006, 47, 1144-52. | ||
| 4. Nunn A.D. et al. Preclinical evaluation of 177Lu-AMBA, a radiolabelled peptide for systemic radiotherapy and imaging of prostate cancer by targeting gastrin releasing peptide receptors. Eur. J. Cancer Suppl. 2004, 2, 89. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1